Dimercaprol Production Cost Reports

The report provides a detailed analysis essential for establishing a Dimercaprol production plant. It encompasses all critical aspects necessary for Dimercaprol production, including the cost of Dimercaprol production, Dimercaprol plant cost, Dimercaprol production costs, and the overall Dimercaprol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Dimercaprol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Dimercaprol is a chelating agent that is primarily used in the treatment of heavy metal poisoning, such as lead, arsenic, and mercury toxicity. It is widely utilised in the treatment of acute arsenic poisoning, where it is administered to prevent damage to organs such as the liver and kidneys. It works by binding to these toxic metals in the body and helping to remove them through urine, thus reducing their toxic effects. It is used in the treatment of lead poisoning, especially in cases of acute exposure. It also finds its application in medical practices where there is a need to chelate metals, helping to prevent their harmful accumulation in the body. In addition to its use in poisoning, dimercaprol is also sometimes used in the treatment of Wilson's disease, which is a condition where copper builds up in the body.

The primary factor that drives the market for Dimercaprol is its usage as an antidote for poisoning caused by heavy metals like arsenic, mercury, and lead, which boosts its market growth. Its application as a chelating agent in emergency medical settings to treat acute poisoning cases further supports its demand in the medical and healthcare sectors. Its demand in the management of certain conditions caused by toxic metals, such as mercury poisoning, significantly contributes to its market growth.

Its application as a medication in managing Wilson’s disease, which is a condition involving copper buildup in the body, further contributes to its demand in the pharmaceutical industry. Its demand in laboratory settings for research involving toxicology and chelation therapy also adds to its market expansion. Technological advancements in production methods, along with the reliability of suppliers, sustainability initiatives, and effective logistics, all play a crucial role in shaping global procurement processes for Dimercaprol. Industrial Dimercaprol procurement is influenced by factors such as the cost and availability of key raw materials, including specialised chemicals for synthesis, regulatory standards, and environmental guidelines.

Raw Material for Dimercaprol Production

According to the Dimercaprol production plant project report, the major raw materials for Dimercaprol production include Sodium Hydroxide, Hydrogen Sulfide, and 2,3-Dibromopropanol.

Production Process of Dimercaprol

The extensive Dimercaprol production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of Dimercaprol begins with saturating a methanol solution of sodium hydroxide (NaOH) with hydrogen sulfide to form sodium hydrogen sulfide (NaSH). Then, 2,3-dibromopropanol is added to the solution, and the mixture is heated at 40 degree Celsius under pressure. The complete reaction leads to the formation of 2,3-dimercapto-1-propanol or Dimercaprol as the final product.

Dimercaprol is also known as British Anti-Lewisite (BAL). It is a chelating agent which is currently used in the treatment of acute heavy metal poisoning, including arsenic, mercury, gold, and lead. It appears as a colourless to slightly yellowish viscous oily liquid with a characteristically pungent mercaptan odour. The molecular formula of the compound is C3H8OS2, and its molecular mass is 124.21 g/mol. Its density ranges from 1.239 to 1.259 g/cm³, and it has a melting point of 77 degree Celsius and a boiling point of 120 degree Celsius at 15 mm Hg. The IUPAC name of the compound is 2,3-Dimercaptopropan-1-ol. Its aqueous solution is not stable, which is why it is formulated as an intramuscular injection suspended in peanut oil or arachis oil with benzyl benzoate as a stabiliser. The compound must be protected from light and stored in hermetically sealed vials to maintain stability. It may cause some serious side effects include nephrotoxicity, hypertension, fever, and the potential redistribution of certain metals like mercury to sensitive brain tissues due to its lipophilic nature. It is contraindicated in cadmium poisoning as the dimercaprol-cadmium complex is highly nephrotoxic. It should not be used in patients with peanut allergies due to its oil-based formulation.